TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›NSTS›Financials
Annual statements · SEC XBRL · FY2020 – FY2025

NSTS Bancorp, Inc. (NSTS) financials

Income statement

NSTS Bancorp, Inc. (NSTS) income statement, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Revenue$255K$289K$291K$270K$256K$252K
Revenue growth—13.3%0.7%-7.2%-5.2%-1.6%
Net income-$112K-$55.0K$27.0K-$3.96M-$789K-$386K
Net margin-43.9%-19.0%9.3%-1465.6%-308.2%-153.2%

Cash flow

NSTS Bancorp, Inc. (NSTS) cash flow, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$620K$1.45M$2.99M$431K$9.43M$4.05M
Capital expenditures$104K$142K$215K$516K$319K$104K
Free cash flow-$724K$1.31M$2.77M-$85.0K$9.11M$3.95M
Share buybacks——$0.00$2.38M$970K$0.00

Balance sheet

NSTS Bancorp, Inc. (NSTS) balance sheet, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$31.9M$122M$13.1M$31.4M$53.5M$34.0M
Total assets$242M$341M$264M$257M$279M$267M
Total liabilities$195M$296M$184M$179M$202M$187M
Shareholders' equity$46.7M$45.2M$80.5M$77.5M$76.5M$80.0M
Retained earnings$45.3M$45.3M$45.3M$41.1M$40.3M$39.9M
Shares (wtd avg diluted)——4.73M5.00M4.91M4.89M

Every figure is extracted from NSTS Bancorp, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is NSTS Bancorp, Inc.'s annual revenue?
NSTS Bancorp, Inc. (NSTS) reported $252K of revenue for fiscal year 2025 — down 1.6% from $256K in FY2024, per its annual report filed with the SEC.
Is NSTS Bancorp, Inc. profitable?
Not in FY2025 — NSTS reported a net loss of $386K, per SEC filings.
What is NSTS Bancorp, Inc.'s free cash flow?
$3.95M in FY2025 (operating cash flow $4.05M minus $104K of capital expenditures), from the SEC cash-flow statement.
Does NSTS pay a dividend?
NSTS Bancorp, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full NSTS analysis — verdict, score & filings →Is NSTS a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.